Indivior Pharmaceuticals, Inc. (INDV) · Nov 3, 2026 · Other events
Conversion terms reset — 24.0033→30.9355 shares per $1,000; no conversions
Supernus disclosed a mechanical convertible-note adjustment following Indivior’s special dividend. The reset changes dilution terms, not the combined company’s operating story.
Supernus is now the combined Indivior–Supernus CNS company following the merger completed on November 2, 2026, with a broader marketed portfolio, pipeline, and expected cost synergies. This filing is a mechanical post-dividend adjustment, not a new business development. The $1 billion special dividend was already announced and tied to the merger closing, so the note reset was an expected consequence rather than fresh information.
| Note terms | Filing figure | Comparison |
|---|---|---|
| Coupon (Notes) | 0.625% | 2031 maturity |
| Conversion rate (Notes) | 30.9355 shares per $1,000 (Financial terms) | 24.0033 previously |
| Conversion price (Financial terms) | $32.33 per share | — |
The adjustment mainly reallocates potential dilution between shareholders and bondholders. The conversion rate rises from 24.0033 to 30.9355 shares per $1,000, reflecting the special dividend under the indenture. That gives noteholders a lower effective conversion price after the cash distribution, but it does not raise new capital or change the combined company’s operating plan.
There is no immediate dilution from this notice. The filing says no bondholders converted their notes into common stock. 〔0〕 The adjustment therefore changes the potential future share count, while leaving current ownership and operations untouched.
Bottom line: This is routine merger-and-dividend plumbing, not a change to Supernus’s business trajectory. It confirms the expected noteholder protection mechanism and adds no new operating signal.
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!